Nkarta, Inc.

General ticker "NKTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $298.4M (TTM average)

Nkarta, Inc. does not follow the US Stock Market performance with the rate: -18.4%.

Estimated limits based on current volatility of 3.9%: low 1.83$, high 1.98$

Factors to consider:

  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.21$, 3.80$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.71$, 2.28$]

Financial Metrics affecting the NKTX estimates:

  • Negative: Non-GAAP EPS, $ of -1.66 <= 0.04
  • Negative: Operating cash flow per share per price, % of -36.86 <= 1.79
  • Negative: negative Operating income
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Positive: Interest expense per share, $ of 0 <= 0
  • Negative: Shareholder equity ratio, % of 81.40 > 63.75
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term NKTX quotes

2025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-091.41.51.61.71.81.922.12.22.3
Price $

Long-term NKTX plot with estimates

0246810121416Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.6−0.4−0.20
NKTXS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $118.95MM $131.65MM $128.19MM
Operating Income $-118.95MM $-131.65MM $-128.19MM
Non-Operating Income $4.59MM $14.84MM $19.40MM
R&D Expense $90.90MM $96.77MM $87.59MM
Income(Loss) $-114.37MM $-116.81MM $-108.79MM
Profit(Loss)* $-119.42MM $-117.50MM $-108.79MM
Stockholders Equity $372.21MM $273.29MM $407.98MM
Inventory $4.23MM $0.00MM $0.00MM
Assets $472.94MM $378.88MM $501.20MM
Operating Cash Flow $-57.00MM $-86.16MM $-99.70MM
Capital expenditure $47.11MM $28.15MM $4.41MM
Investing Cash Flow $-184.69MM $79.02MM $-129.56MM
Financing Cash Flow $219.01MM $0.69MM $226.08MM
Earnings Per Share** $-2.74 $-2.40 $-1.60

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.